Results of ovary tumor treatment with abdominally administered198Au evaluated on the basis of long term follow up

Pathology & Oncology Research

Mihály Patyánik¹  István Polgár¹  Árpád Mayer¹ 

[1] Uzsoki Hospital$$

关键词: radionuclide therapy;   

DOI  :  10.1007/BF03033702

学科分类：生理学与病理学

来源: Springer

【 摘 要 】

In the period between 1959 and 1980 165 patients-previously operated with ovarian tumor-were treated by intraperitoneally administered¹⁹⁸Au in the Oncoradiological Centre of the Uzsoki Hospital. The stage distribution of the 158 patients with common epithelial histology was as it follows: Stage I/A 31; Stage I/B 9; Stage I/C 59; Stage II/A 19; Stage II/B 11; Stage II/C 7, Stage III/A 22. The five year survival result is the next: Stage I/A 90%; Stage I/B 78%; Stage I/C 58%; Stage II/A 26%; Stage II/B 27%; Stage II/C 14%; Stage III/A 18%. From the other 7 patients six had sex cord tumor and one lipid cell tumor. The number of the side effects is in good agreement with the data in literature. The use of¹⁹⁸Au for intraperitoneal treatment of ovary tumors is not contemporary today because of gamma radiation of radiogold, but intraperitoneal radiation treatment should not be forgotten.

【 授权许可】

Unknown